Literature DB >> 16165087

Molecular dynamics studies of the full-length integrase-DNA complex.

Laura De Luca1, Giulio Vistoli, Alessandro Pedretti, Maria Letizia Barreca, Alba Chimirri.   

Abstract

We have carried out a molecular dynamics (MD) simulation of full-length HIV-1 integrase (IN) dimer complexed with viral DNA with the aim of gaining information about the enzyme motion and investigating the movement of the catalytic flexible loop (residues 140-149) thought to be essential in the catalytic mechanism of IN. During the simulation, we observed quite a different behavior of this region in the presence or absence of the viral DNA. In particular, the MD results underline the crucial role of the residue Tyr143 in the mechanism of integration of viral DNA into the host chromosome. The present findings confirm the experimental data (e.g., site-directed mutagenesis experiments) showing that the loop is involved in the integration reactions and its mobility is correlated with the catalytic activity of HIV-1 integrase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165087     DOI: 10.1016/j.bbrc.2005.08.211

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

2.  Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding.

Authors:  Zhuojun Zhao; Christopher J McKee; Jacques J Kessl; Webster L Santos; Janet E Daigle; Alan Engelman; Gregory Verdine; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2007-12-19       Impact factor: 5.157

Review 3.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

4.  Crystal structures of catalytic core domain of BIV integrase: implications for the interaction between integrase and target DNA.

Authors:  Xue Yao; Shasha Fang; Wentao Qiao; Yunqi Geng; Yuequan Shen
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

5.  Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.

Authors:  Michael Topper; Yang Luo; Maria Zhadina; Kevin Mohammed; Leonard Smith; Mark A Muesing
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.

Authors:  Selami Ercan; Necmettin Pirinccioglu
Journal:  J Mol Model       Date:  2013-08-02       Impact factor: 1.810

7.  A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.

Authors:  Cláudio Nahum Alves; Sergio Martí; Raquel Castillo; Juan Andrés; Vicent Moliner; Iñaki Tuñón; Estanislao Silla
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

8.  The HIV-1 integrase mutations Y143C/R are an alternative pathway for resistance to Raltegravir and impact the enzyme functions.

Authors:  Sandrine Reigadas; Guerric Anies; Bernard Masquelier; Christina Calmels; Lieven J Stuyver; Vincent Parissi; Herve Fleury; Marie-Line Andreola
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

9.  Modeling a new water channel that allows SET9 to dimethylate p53.

Authors:  Qifeng Bai; Yulin Shen; Xiaojun Yao; Fang Wang; Yuping Du; Qin Wang; Nengzhi Jin; Jun Hai; Tiejun Hu; Jinbo Yang
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

10.  A dynamic model of HIV integrase inhibition and drug resistance.

Authors:  Alex L Perryman; Stefano Forli; Garrett M Morris; Catherine Burt; Yuhui Cheng; Michael J Palmer; Kevin Whitby; J Andrew McCammon; Chris Phillips; Arthur J Olson
Journal:  J Mol Biol       Date:  2010-01-22       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.